The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 29 March 2004 doi:10.1084/jem.20031389
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 7, 947-957
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 254K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jahng, A.
Right arrow Articles by Kumar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jahng, A.
Right arrow Articles by Kumar, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide

Alex Jahng1, Igor Maricic1,2, Carlos Aguilera2, Susanna Cardell3, Ramesh C. Halder2, and Vipin Kumar1,2

1 La Jolla Institute for Allergy and Immunology (LIAI), and 2 Laboratory of Autoimmunity, Torrey Pines Institute for Molecular Studies (TPIMS), San Diego, CA 92121
3 Lund University, 221 00 Lund, Sweden

Address correspondence to Vipin Kumar, Laboratory of Autoimmunity, Torrey Pines Institute for Molecular Studies, 3550 General Atomics Ct., San Diego, CA 92121. Phone: (858) 455-3870; Fax: (858) 455-3804; email: Vkumar{at}tpims.org

Class I and class II MHC-restricted T cells specific for proteins present in myelin have been shown to be involved in autoimmunity in the central nervous system (CNS). It is not yet known whether CD1d-restricted T cells reactive to myelin-derived lipids are present in the CNS and might be targeted to influence the course of autoimmune demyelination. Using specific glycolipid-CD1d tetramers and cloned T cells we have characterized a T cell population reactive to a myelin-derived glycolipid, sulfatide, presented by CD1d. This population is distinct from the invariant V{alpha}14+ NK T cells, and a panel of V{alpha}3/V{alpha}8+ CD1d-restricted NK T cell hybridomas is unable to recognize sulfatide in the presence of CD1d+ antigen-presenting cells. Interestingly, during experimental autoimmune encephalomyelitis a model for human multiple sclerosis, sulfatide-reactive T cells but not invariant NK T cells are increased severalfold in CNS tissue. Moreover, treatment of mice with sulfatide prevents antigen-induced experimental autoimmune encephalomyelitis in wild-type but not in CD1d-deficient mice. Disease prevention correlates with the ability of sulfatide to suppress both interferon-{gamma} and interleukin-4 production by pathogenic myelin oligodendrocyte glycoprotein-reactive T cells. Since recognition of sulfatide by CD1d-restricted T cells has now been shown both in mice and humans, study of murine myelin lipid-reactive T cells may form a basis for the development of intervention strategies in human autoimmune demyelinating diseases.

Key Words: sulfatides • CD1d • EAE • NK T cells • glycolipids

Abbreviations used in this paper: CGT, UDP-galactose ceramide galactosyltransferase; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; GalCer, galactosyl ceramide; MBP, myelin basic protein; MS, multiple sclerosis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS